BC Innovations | May 1, 2014
Distillery Therapeutics

Indication: Endocrine/metabolic disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Obesity Amylase a1A (AMY1A); AMY1B; AMY1C Genetic studies identified an association between copy number variants of the salivary amylase genes and obesity that could...
Items per page:
1 - 1 of 1